Biotech returning to outperformance
Comment of the Day

September 28 2018

Commentary by Eoin Treacy

Biotech returning to outperformance

Eoin Treacy's view

The Nasdaq-Biotechnology Index broke out of a long base in 2011 and hit a medium-term peak in 2015. It found a medium-term low in 2016 and has held a choppy uptrend since; with two yearlong ranges one above another. The Index rallied this week to test its recovery high and a clear downward dynamic would be required to check the upward bias.

Click HERE to subscribe to Fuller Treacy Money Back to top